Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease
Authors:
- Eric TrépoETEric Trépo
- Delphine DegréDDDelphine Degré
- Thierry GustotTGThierry Gustot
- Laurine VersetLVLaurine Verset
- Pieter DemetterPDPieter Demetter
- Jacques DevièreJDJacques Devière
- Michael AdlerMAMichael Adler
- Christophe MorenoCMChristophe Moreno
- 1 September 2015
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 27 (9) , 1074-1079
Abstract
Fibroscan (FS) is a reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in chronic liver disease. However, there is no clear consensus with respect to the best FS cut-off values for use in alcoholic liver disease (ALD). The aims of this study were as follows: (a) to compare the performance of FS and different biochemical markers in ALD patients; (b) to assess the best FS cut-off values for the prediction of fibrosis stage in our ALD population; and (c) to assess the influence of aspartate aminotransferase (AST) values on FS. This retrospective study included 135 consecutive and compensated ALD patients who underwent liver biopsy between November 2006 and March 2012 at Erasme Hospital. FS, Fibrotest, FIB-4, aspartate aminotransferase to platelet ratio index (APRI), and Forns' scores were tested in all patients. The diagnostic accuracy of FS was 0.89 (95% confidence interval: 0.83-0.95) for the diagnosis of advanced fibrosis and 0.93 (95% confidence interval 0.90-0.97) for the diagnosis of cirrhosis. FS performed better than Fibrotest (0.81 and 0.88), APRI (0.65 and 0.75), Forns' (0.64 and 0.78), and FIB-4 (0.70 and 0.73). The optimal cut-off values of liver stiffness (LS) for predicting METAVIR fibrosis stage F≥3 and F4 disease were 10.3 and 18.0 kPa, respectively. AST showed a significant positive correlation with LS (r=0.24, P=0.001). However, exclusion of patients with AST more than 50 IU/l only lowered the LS cut-off for the diagnosis of F4 (14 vs. 18.0 kPa). FS is currently the most reliable noninvasive method for the diagnosis of advanced liver fibrosis and cirrhosis in ALD.Keywords
This publication has 34 references indexed in Scilit:
- Alcoholic Liver Disease: Pathogenesis and New Therapeutic TargetsGastroenterology, 2011
- Increased liver stiffness in alcoholic liver disease: Differentiating fibrosis from steatohepatitisWorld Journal of Gastroenterology, 2010
- The usefulness of transient elastography to diagnose cirrhosis in patients with alcoholic liver diseaseThe Korean Journal of Hepatology, 2009
- Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease†Hepatology, 2008
- Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non‐invasive laboratory testsAlimentary Pharmacology & Therapeutics, 2008
- Meta-analyses of FibroTest diagnostic value in chronic liver diseaseBMC Gastroenterology, 2007
- FIB-4Hepatology, 2007
- Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis CHepatology, 2004
- Sampling Variability of Liver Fibrosis in Chronic Hepatitis CHepatology, 2003
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996